IL6 and periodontal disorder: Future prospective studies should include larger and more diverse cohorts, standardized follow-up intervals, and comprehensive behavioral and metabolic data to validate the clinical utility of systemic cytokines, particularly IL-6, as biomarkers of periodontal disease activity and treatment response.